Prostatis Group Portfolio holdings
Top Buys
| 1 |
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
|
+$7.39M |
| 2 |
Invesco S&P 500 GARP ETF
SPGP
|
+$6.43M |
| 3 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$5.75M |
| 4 |
Invesco S&P MidCap Momentum ETF
XMMO
|
+$4.4M |
| 5 |
FT Vest Fund of Deep Buffer ETFs
BUFD
|
+$3.66M |
Top Sells
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$25.7M |
| 2 |
HDV
iShares Core High Dividend ETF
HDV
|
+$5.62M |
| 3 |
Vanguard Information Technology ETF
VGT
|
+$580K |
| 4 |
Vanguard High Dividend Yield ETF
VYM
|
+$316K |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$311K |
Sector Composition
| 1 | Healthcare | 6.05% |
| 2 | Technology | 5.14% |
| 3 | Consumer Discretionary | 4.26% |
| 4 | Financials | 3.23% |
| 5 | Communication Services | 1.74% |
Similar funds
Prostatis Group's Q3 2022 Portfolio in Review
As of Q3 2022, Prostatis Group held 75 positions worth $86.8M, up 35% from $64.2M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Prostatis Group deployed $29.2M of net new capital in Q3 2022, opening 28 new positions and adding to 19 existing holdings. Its largest new stake was Pacer Lunt Large Cap Multi-Factor Alternator ETF: 206,903 shares worth $6.6M.
By sector, the portfolio is most concentrated in Healthcare at 6% of assets, up from 4.6% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was First Trust Enhanced Short Maturity ETF, an estimated $25.7M trimmed.
- Prostatis Group's largest Q3 2022 buy was Pacer Lunt Large Cap Multi-Factor Alternator ETF: 206,903 shares worth $6.6M.
- Prostatis Group added most to Amplify CWP Enhanced Dividend Income ETF in Q3 2022, an estimated $1.71M increase.
- Prostatis Group's biggest Q3 2022 reduction was First Trust Enhanced Short Maturity ETF, cutting an estimated $25.7M.
- Prostatis Group fully exited iShares Core High Dividend ETF in Q3 2022, selling an estimated $5.62M.
- Prostatis Group's ten largest holdings make up 54% of its $86.8M portfolio in Q3 2022.
- Prostatis Group opened 28 new positions and closed 11 in Q3 2022.
- Prostatis Group's portfolio value rose 35% quarter-over-quarter to $86.8M.
Based on Prostatis Group's 13F filing for Q3 2022, filed 23 Mar 2023.